View Article

  • Formulation and Evaluation of Microneedle Based Transdermal Drug Delivery System by Using Antihypertensive Drug

  • Department of Pharmaceutics, Vidyabharti College of Pharmacy, Sant Gadge Baba University, Amravati 444602, Maharashtra, India 

Abstract

The present study focuses on the formulation and evaluation of microneedle-based transdermal drug delivery systems (TDDS) using Timolol Maleate, a beta-blocker employed in hypertension management. The primary objective was to develop a patient-compliant, painless, and effective delivery system to overcome the limitations of conventional oral therapy. Microneedle patches were prepared using the solvent evaporation method with polymers such as PVA, PVP K30, HPMC E4M, and HPMC K4M, and plasticizers like glycerine and PEG 400, with distilled water and ethanol as solvents. The optimized formulation showed favorable physical characteristics, including uniform thickness (210–400 µm), acceptable weight variation (±2.6% to ±6.4%), and good drug content (57.23% to 81.32%). SEM analysis revealed uniform structures without sharp needle tips. In vitro drug release ranged from 6.98% to 98.6%, with a cumulative drug release (CDR) of up to 98.6% and a permeation flux of 0.143 mg/cm²/min. Kinetic studies indicated that the drug release followed zero-order kinetics (R² = 0.9878), suggesting a sustained release profile. Stability studies showed that the patches remained most stable at room temperature over 30 days. These results support that the developed microneedle patch offers a promising and non-invasive alternative for controlled transdermal delivery of antihypertensive drugs, ensuring improved patient compliance and effective blood pressure control.

Keywords

Microneedles, Transdermal Drug Delivery System, PVA, PVP K30, Timolol Maleate

Introduction

1.1. Transdermal drug delivery system:

Definition – Transdermal drug delivery system is defined as self-contained, self-discrete dosage forms, which when applied to the intact skin deliver the drug at a controlled rate to the systemic circulation. (1,2) Transdermal drug delivery (TDD) is a route of drug delivery for treating or preventing disease by absorbing drugs through the skin, permeating into the skin and further into the blood circulation. TDD avoids first-pass effects, prolongs the action of drugs with short half-lives through slow release and avoids fluctuations in blood levels, reduces side effects and improves patient compliance. The stratum corneum barrier plays a key role in TDD, and many methods have been used to improve the efficiency of TDD, including the use of chemical penetration enhancers and different physical enhancement approaches, such as micro-needling, iontophoresis, electroporation, laser ablation and ultrasound facilitation. (3)

    1.  Microneedle Based Transdermal Drug Delivery Systems:

In recent years, microneedles have gained widespread interest in TDD and have shown Brilliant achievements in delivering both chemical small molecules and biomacromolecules whilst being minimally invasive and painless. (4,5) Microneedles usually consist of micrometer-sized needles (50–900 µm in length) in the form of microneedle arrays that can successfully penetrate. the stratum corneum and deliver drugs in a minimally invasive manner below the stratum corneum without damaging blood vessels and nerves in the dermis (6,7), improving patient compliance and allowing drugs exposed in the epidermis or dermis to be rapidly absorbed by surrounding capillaries and lymph nodes. (8-10) Microneedles or Micro-needle patches or Microarray patches are micron-scaled medical devices used to administer vaccines, drugs, and other therapeutic agents.(11) While microneedles were initially explored for transdermal drug delivery applications, their use has been extended for the intraocular, vaginal, transungual, cardiac, vascular, gastrointestinal, and intracochlear delivery of drugs.(12) Microneedles are constructed through various methods, usually involving photolithographic processes or micro moulding. These methods involve etching microscopic structure into resin or silicon in order to cast microneedles. Microneedles are made from a variety of material ranging from silicon, titanium, stainless steel, and polymers. Some microneedles are made of a drug to be delivered to the body but are shaped into a needle so they will penetrate the skin. Stimuli-responsive microneedles are advanced devices that respond to environmental triggers such as temperature, pH, or light to release therapeutic agents. The arrays are applied to the skin of patients and are given time to allow for the effective administration of drugs. Microneedles are an easier method for physicians as they require less training to apply and because they are not as hazardous as other needles, making the administration of drugs to patients safer and less painful while also avoiding some of the drawbacks of using other forms of drug delivery, such as risk of infection, production of hazardous waste, or cost. (13)

1.3. Types of Microneedles:

As aforementioned, a microneedle is a micron-sized needle with a height of 10–2000 µm, and width of 10–50 µm, and are widely used in transdermal drug delivery systems to the advantage of safe, painless, convenient, non-invasive and efficient drug delivery.50- 51 Microneedles can create pores on the skin and enable the drug to penetrate through the epidermis layer to the dermal tissue directly. Unlike regular hypodermic needles, the microneedle has the ability to improve patient compliance as it does not hurt nerves. What is more, the microneedle delivery system delivers drugs transdermally, hereby improving the bioavailability of drugs via avoiding hepatic first pass metabolism. The drug delivery mechanisms of these microneedles (respectively) are the “poke and patch” approach, the “coat and poke” approach, the “poke and release” approach, and the “poke and flow” approach. We will subsequently introduce each type of microneedle in more detail, along with examples of successful use cases of each. (14,17) Morphologically, microneedles are classified into five types namely:

  1. Solid microneedles
  2. Coated microneedles
  3. Dissolving microneedles
  4. Hollow microneedles
  5. Hydrogel-Forming microneedles.

1.4. Advantages of Microneedle Patch:

  1. Minimally invasive
  2. Pain-free
  3. Enhanced drug absorption
  4. Reduced dosing frequency
  5. Improved patient compliance
  6. Large molecules can be administered
  7. Painless administration of the active pharmaceutical Ingredient
  8. First-pass metabolism is avoided
  9. Faster healing at injection site than with a hypodermic needle,
  10. Decreased microbial penetration as compared with a hypodermic needle, the microneedle punctures only the epidermis
  11. Specific skin area can be targeted for desired drug delivery enhanced drug efficacy may result in dose reduction
  12. Good tolerability without long-term oedema or erythema
  13. Rapid drug delivery can be achieved by coupling the microneedles with other technologies. (18)

1.5. Disadvantages of Microneedle:

  1. Careful use of the device may be needed to avoid particles ‘bouncing off’ the skin surface.
  2. The thickness of the stratum cornea and other skin layers varies between individuals and so penetration depth of particles could vary too.
  3. The external environment, like hydration of the skin, could affect delivery.
  4. Repetitive injection may collapse the veins.
  5. The tip of the microneedle may break off and remain within the skin on removal of the patch. (19)

1.6. Material Compositions of Microneedles:

Microneedles can be made from various different materials, each yielding different characteristics and these materials can be used to prepare different kinds of microneedles via different methods. (20) The materials of microneedles can be divided into various types:

  1. Metal materials
  2. Inorganic materials
  3. Polymer materials
  4. Glass materials
  5. Ceramic materials.

1.7. Various Methodologies/Techniques:

There are Various Methodologies/Techniques involved in Microneedles Applications is as follows:

1.7.a. Poke with patch or poke and flow approach:

It involves pressing of solid microneedles array on the skin to produce microspores followed by the application of patch or liquid formulation containing therapeutic agent. The microspores formed allow the easy passage of drug in to the deeper tissues of the skin.

1.7.b. Coat and poke approach:

In this method, microneedle array is first coated with drug and then inserted into skin. Upon insertion, the drug-coated on the microneedles dissolves in the aqueous pores followed by permeation in to the surrounding skin tissues and microcirculation.

1.7.c. Scratch and patch approach:

It is a variation of poke and patch approach, where microneedle array is scraped over the skin and then applying patch or liquid formulation.

1.7.d. Dip and scrape:

In this approach, microneedles are first dipped into drug solution and then scraped across the skin surface to leave behind the drug within micro abrasions created by the needles.

1.7.e. Poke and release approach:

In this approach, the drug can be encapsulated within soluble sugar or biodegradable polymeric microneedles, followed by the insertion into the skin to achieve either fast or controlled drug release. Poke with flow: In this approach, hollow microneedle array is pressed on the skin to create micro-channels in the skin followed by infusion of liquid formulations in to deeper skin tissues across the needle pores. (21)

2. Preformulation Studies:

Preformulation studies are investigations of the physical and chemical properties of a timolol maleate, such as organoleptic properties, solubility, melting point, and compatibility with polymer by using FTIR spectroscopy. Analytical method development: A simple, accurate, and precise UV-visible spectrophotometric method was developed and validated for the quantitative estimation of timolol maleate in accordance with ICH guidelines. The goal is to generate data that informs formulation design and development, resulting in a stable, safe, and effective drug product.

2.1. Fabrication of microneedle patch:

For formulation of microneedle patch Polymers like PVA, PVP K30, HPMC E4M, HPMC K4M, Plasticizers like Glycerin, PEG 400 and drug (Timolol maleate) was used. Aqueous blend of polymer and drug were used to fabricate microneedle patches by using different plasticizers with constant volume, as Specified in (Table no. 1 & 2). by observing each formulation, the best formulation batch was optimized.

Table No.1: Formulation of timolol maleate loaded microneedle patches by using Glycerin as plasticizer

Batches

Timolol maleate (mg)

PVA

(mg)

PVA: PVP K30 (9:1) (mg)

HPMC E4M

(mg)

HPMC K4M

(mg)

Glycerin (ml)

Distilled water (ml)

Ethanol (ml)

F1

86.5

200

-

-

-

0.015

5

5

F2

86.5

-

177.77:22.22

-

-

0.015

5

5

F3

86.5

-

-

200

-

0.015

5

5

F4

86.5

-

-

-

200

0.015

5

5

Table No. 2: Formulation of timolol maleate loaded microneedle patches by using PEG 400 as plasticizer.

Batches

Timolol maleate

(mg)

PVA

(mg)

PVA: PVP K30 (9:1) (mg)

HPMC E4M

(mg)

HPMC K4M

(mg)

PEG 400

(ml)

Distilled water (ml)

Ethanol (ml)

F5

86.5

200

-

-

-

0.017

5

5

F6

86.5

-

177.78: 22.22

-

-

0.017

5

5

F7

86.5

-

-

200

-

0.017

5

5

F8

86.5

-

-

 

200

0.017

5

5

86.5 mg of timolol maleate and varying amounts of polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP K30) in ration 9:1 were dissolved in same volumes of distilled water and ethanol in ration 1:1 by keeping glycerin amount constant (as shown in table no. 3), then applying gentle heat using water bath. Distilled water and ethanol was selected as solvent owing to better solubility of drug in it. These polymer matrix solutions were transferred into ABS micromolds, and allowed to dry in vacuum desiccator for 24 h. After 24 h, microneedle patches were retrieved from micromolds and preserved in a moisture resistant container along with silica.

Table No.3: Formulation of Microneedle patch by increasing concentration of PVA: PVP K30 (9:1)

Batches

Timolol maleate (mg)

PVA: PVP K30 (9:1) (mg)

Glycerin (ml)

Distilled water (ml)

Ethanol (ml)

1

86.5

177.77: 22.22

0.015

5

5

2

Reference

  1. Kiran Ingole, Transdermal Drug Delivery System (TDDS): A Review, International Journal of Research Publication and Reviews www.ijrpr.com ISSN 2582-7421
  2. https://www.slideshare.net/slideshow/transdermal-drug-delivery-system- 13541191/13541191
  3. Hou X, Li J, Hong Y, Ruan H, Long M, Feng N, Zhang Y, Advances and Prospects for Hydrogel-Forming Microneedles in Transdermal Drug Delivery, Biomedicines 2023, 11, 2119, https://doi.org/10.3390/biomedicines11082119
  4. Courtenay A J, Mccrudden M T C, Mcavoy K J, et al. Microneedle-Mediated Transdermal Delivery of Bevacizumab. Mol Pharm, 2018, 15(8): 3545-56.
  5. Vora L K, Moffatt K, Tekko I A, et al. Microneedle array systems for long-acting drug delivery. Eur J Pharm Biopharm, 2021, 159: 44-76.
  6. Donnelly R, Douroumis D. Microneedles for drug and vaccine delivery and patient monitoring. Drug Deliv Transl Res, 2015, 5(4): 311-2.
  7. Zhang Y, Yu J, Kahkoska A R, et al. Advances in transdermal insulin delivery. Adv Drug Deliv Rev, 2019, 139: 51-70.
  8. Rzhevskiy A S, Singh T R R, Donnelly R F, et al. Microneedles as the technique of drug delivery enhancement in diverse organs and tissues. J Control Release, 2018, 270: 184-202.
  9. Ye Y, Yu J, Wen D, et al. Polymeric microneedles for transdermal protein delivery. Adv Drug Deliv Rev, 2018, 127: 106-18.
  10. Gowda, B.H. Jaswanth, Ahmed Mohammed Gulzar, Sahebkar Amirhossein, Riadi Yassine, Shukla Rahul, Kesharwani Prashant, "Stimuli-Responsive Microneedles as a Transdermal   Drug    Delivery           System: A Demand-Supply Strategy", Biomacromolecules. 23 (4), 2022, 1519–1544
  11. Dharadhar S, Majumdar A, Dhoble S, Patravale V (February 2019). "Microneedles for transdermal drug delivery: a systematic review". Drug Development and Industrial Pharmacy. 45 (2): 188–201.
  12. Panda A, Matadh VA, Suresh S, Shivakumar HN, Murthy SN (January 2022). "Non-dermal applications of microneedle drug delivery systems". Drug Delivery and Translational Research. 12 (1): 67–78.
  13. Donnelly Ryan F, Woolfson A David, “Patient Safety and Beyond: What Should We Expect from Microneedle Arrays in the Transdermal Delivery Arena?”, Therapeutic Delivery. 5 (6), June 2014, 653–662.
  14. Ying Hao, Wei Li, Xing Li Zhou, Fan Yang, and Zhi Yong Qian, Microneedles Based Transdermal Drug Delivery Systems, Journal of Biomedical Nanotechnology, Vol. 13, 2017, 1581–1597
  15. Kim Y.C., Park J.H., Prausnitz M.R. Microneedles for drug and vaccine delivery. Drug Deliv. Transl. Res. 2015; 5:311–312. doi: 10.1016/j.addr.2012.04.005.
  16. Dang N., Liu T.Y., Prow T.W. Micro and Nanotechnology in Vaccine Development. William Andrew Publishing; Norwich, NY, USA: 2017. Nano-and Microtechnology in Skin Delivery of Vaccines.
  17. Waghule T., Singhvi G., Dubey S.K., Pandey M.M., Gupta G., Singh M., Dua K. Microneedles: A smart approach and increasing potential for transdermal drug delivery system. Biomed. Pharmacother. 2018; 109:1249–1258.
  18. https://www.slideshare.net/samikshasawant146/microneedles-in-transdermal-drug- delivery
  19. Aldawood FK, Andar A, Desai S, A Comprehensive Review of Microneedles: Types, Materials, Processes, Characterizations and Applications. Polymers (Basel), 22;13(16), Aug 2021, 2815.
  20. M. Witting, K. Obst, M. Pietzsch, W. Friess, and S. Hedtrich, Feasibility study for intraepidermal delivery of proteins using a solid Microneedle array, Int. J. Pharm, 2015, 486, 52.
  21. Rabinarayan Parhi and N. Divya Supriya, Review of Microneedle based Transdermal Drug Delivery Systems, International Journal of Pharmaceutical Sciences and Nanotechnology, Volume 12, Issue 3, June 2019, 1-2-19.
  22. Henry, S., McAllister, D. V., & Langer, R., "Microfabricated microneedles: A novel approach to transdermal drug delivery." Journal of Pharmaceutical Sciences, 92(11), 2003, 1961-1969.
  23. Donnelly, R. F., Singh, T. R. R., & Woolfson, A. D., Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety. Drug Delivery, 17(4), 2010, 187–207.
  24. Prabhu, A., Jose, J., Kumar, L. et al. Transdermal Delivery of Curcumin- Loaded Solid Lipid Nanoparticles as Microneedle Patch: an In Vitro and In Vivo Study. AAPS Pharm SciTech 23, 2022, 49.
  25. Larrañeta E, Stewart S, Fallows SJ, Birkhäuer LL, McCrudden MT, Woolfson AD, Donnelly RF. A facile system to evaluate in vitro drug release from dissolving microneedle arrays. Int J Pharm, Jan 2016, 30;497(1-2):62-9.
  26. Jaymin C. Shah, Analysis of permeation data: evaluation of the lag time method, International Journal of Pharmaceutics, Volume 90, Issue 2, 1993, Pages 161-169, ISSN 0378-5173.
  27. Vishal Yadav, Prakash Jadhav, Shailaja Dombe, Anjali Bodhe, Pranali Salunkhe. Formulation and evaluation of microsponge gel for topical delivery of the antifungal drug. Int J Appl Pharm, 9(4), 2017, 30-37.
  28. https://www.slideshare.net/slideshow/dissolution-models-sem-1/75773846
  29. Paarakh M. P., Jose P. A., Setty C., & Peterchristoper, G., Release Kinetics Concepts and Applications, International Journal of Pharmacy Research & Technology (IJPRT), 8(1), 2023, 12–20.
  30. Baker, R. W., et al., "Stability of microneedles and their formulations." Journal of Pharmaceutical Sciences, 100(3), 2011, 1102-1109.
  31. Ravikumar, P.,     &              Muthuvijayan, V., "Stability    and performance of microneedle drug delivery systems." Journal of Controlled Release, 285, 2018, 88-98.
  32. Donnelly, R. F., et al., "Microneedles: A new era in transdermal drug delivery." Drug Development and Industrial Pharmacy, 40(4), 2014, 471-487.
  33. Thomson, S. E., et al., "Stability assessment of coated microneedles for vaccine delivery." Vaccine, 37(4), 2019, 575-585.
  34. Kievit, M. et al., "Long-term stability and shelf-life predictions of microneedle drug delivery patches." Journal of Pharmaceutical Innovation, 47(1), 2022, 111-121.

Photo
Kiran Indore
Corresponding author

Department of Pharmaceutics, Vidyabharti College of Pharmacy, Sant Gadge Baba University, Amravati 444602, Maharashtra, India

Photo
Shrikant Pande
Co-author

Department of Pharmaceutics, Vidyabharti College of Pharmacy, Sant Gadge Baba University, Amravati 444602, Maharashtra, India

Kiran Indore*, Shrikant Pande, Formulation and Evaluation of Microneedle Based Transdermal Drug Delivery System by Using Antihypertensive Drug, Int. J. Sci. R. Tech., 2025, 2 (7), 228-245. https://doi.org/10.5281/zenodo.15877296

More related articles
A Descriptive Study to Assess the Knowledge of Mot...
Ajay Kawar, Shantanu Kamble, Sarika Satpute, Ashwini Patil, Rupal...
Molecular Mechanisms of SGLT2 Inhibitors Bridging ...
Rushikesh Bhosle, Darshil Ingale, Sachin Amrutkar, Swaraj Dhande,...
Vehicle Black Box System...
Mahmood Thanzeel, Niranjan Thomas B, Sachin Suresh, Sidharth Satyam Krishna, Neetha K. Nataraj, ...
Development and Evaluation of Goat Milk and Papaya-Based Face Wash for Skin Care...
Minakshi Khairnar, Vrushali Bagul, Yogeshwari Sonawane, ...
Related Articles
Knowledge and Attitude Regarding Human Milk Banking Among Antenatal Mothers in S...
Manphun Wangsu, Nongmeikapam Monika, Iarihunlang Lyngdoh, ...
Formulation and Evaluation of a Polyherbal Anti-Dandruff Shampoo Using Ritha, Sh...
Samyak Lonkar , Aishwarya Bhagwat , Gaurav Apar , Ujwal Palve , Amol Teke , Dr. Rao Javvji , ...
Nutritional and Functional Properties of Tamarind (Tamarindus Indica) Leaves: A ...
Prachi Lokhande, Aman Paigambar Mujawar , Ayeshabano Fahim Hawaldar, Afrin Abdul Shaikh , ...
Comparative Analysis of Free Radical Scavenging in Moringa oleifera, Sauropus an...
Nisha Shri Chengamaraju, Chong Man Ning, M. Lakshmi Madhuri, NVL. Suvarchala Reddy, M. Ganga Raju, ...
More related articles
A Descriptive Study to Assess the Knowledge of Mother Regarding Developmental Mi...
Ajay Kawar, Shantanu Kamble, Sarika Satpute, Ashwini Patil, Rupali Watharkar, ...
Molecular Mechanisms of SGLT2 Inhibitors Bridging Glucose Lowering and Cardiac P...
Rushikesh Bhosle, Darshil Ingale, Sachin Amrutkar, Swaraj Dhande, Shreyas Kurhe, ...
A Descriptive Study to Assess the Knowledge of Mother Regarding Developmental Mi...
Ajay Kawar, Shantanu Kamble, Sarika Satpute, Ashwini Patil, Rupali Watharkar, ...
Molecular Mechanisms of SGLT2 Inhibitors Bridging Glucose Lowering and Cardiac P...
Rushikesh Bhosle, Darshil Ingale, Sachin Amrutkar, Swaraj Dhande, Shreyas Kurhe, ...